Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Inflammopharmacology
Sreedhar Amere Subbarao

Abstract

Inflammation is an intrinsic defence mechanism triggered by the immune system against infection or injury. Chronic inflammation allows the host to recover or adapt through cellular and humoral responses, whereas acute inflammation leads to cytokine storms resulting in tissue damage. In this review, we present the overlapping outcomes of cancer inflammation with virus-induced inflammation. The study emphasises how anti-inflammatory drugs that work against cancer inflammation may work against the inflammation caused by the viral infection. It is established that the cytokine storm induced in response to SARS-CoV-2 infection contributes to disease-associated mortality. While cancer remains the second among the diseases associated with mortality worldwide, cancer patients' mortality rates are often observed upon extended periods after illness, usually ranging from months to years. However, the mortality rates associated with COVID-19 disease are robust. The cytokine storm induced by SARS-CoV-2 infection appeared to be responsible for the multi-organ failure and increased mortality rates. Since both cancer and COVID-19 disease share overlapping inflammatory mechanisms, repurposing some anticancer and anti-inflammatory drugs for COVI...Continue Reading

References

Jan 1, 1975·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·I Penn
Jul 1, 1988·Cancer Letters·S J Fey, P M Larsen
Apr 15, 1972·Lancet·R M McAllisterM Green
Jun 27, 1970·Nature·H M Temin, S Mizutani
Jan 1, 1996·The Journal of Allergy and Clinical Immunology·L M SchwiebertL A Schwiebert
Jan 1, 1996·World Journal of Urology·R P Negus, F R Balkwill
Oct 1, 1996·Cytokine & Growth Factor Reviews·J Oppenheim, H Fujiwara
Jan 12, 2000·Oncogene·C S WilliamsR N DuBois
Jul 11, 2000·Japanese Journal of Pharmacology·M Tominaga, D Julius
Oct 18, 2000·The Cochrane Database of Systematic Reviews·M E Suarez-AlmazorE Belseck
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Apr 3, 2001·Annual Review of Neuroscience·M J Caterina, D Julius
Jun 14, 2001·Lancet·J Parkin, B Cohen
Jul 13, 2001·Infectious Disease Clinics of North America·N C KleinB A Cunha
Jul 24, 2001·JAMA : the Journal of the American Medical Association·A D PradhanP M Ridker
Feb 21, 2002·Journal of the National Cancer Institute·Michael J ThunCarlo Patrono
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jan 7, 2004·Nature Reviews. Cancer·Glenn Dranoff
Apr 6, 2004·Trends in Pharmacological Sciences·Jan Vilcek, Marc Feldmann
Oct 19, 2004·Seminars in Cancer Biology·Mary PhilipHans Schreiber
Jan 13, 2005·Environmental and Molecular Mutagenesis·Michael L GatzaSusan J Marriott
Jan 22, 2005·American Journal of Therapeutics·Garry G Graham, Kieran F Scott
May 27, 2005·Biochimica Et Biophysica Acta·Tetsuya MizutaniShigeru Morikawa
Aug 24, 2005·Virology Journal·Martin J VincentStuart T Nichol
Sep 10, 2005·Nature Biotechnology·Gregory P Adams, Louis M Weiner
Sep 20, 2005·Biochimica Et Biophysica Acta·Lorne J Hofseth, Lei Ying
Sep 30, 2005·The New England Journal of Medicine·John H BeigelUNKNOWN Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5
Jan 6, 2006·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Barbara Seliger
Jan 18, 2006·Archives of Dermatology·Danya Sereda, Victoria P Werth
Feb 25, 2006·Cell·Max D Cooper, Matthew N Alder
Apr 11, 2006·Molecular Cancer Research : MCR·Haitian LuChuanshu Huang
Apr 15, 2006·The Oncologist·Remco van HorssenAlexander M M Eggermont
Apr 19, 2006·Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution·Nadia Danilova
Jul 14, 2006·Pharmacology & Therapeutics·Oliver Werz, Dieter Steinhilber
Aug 31, 2006·Cardiovascular Drug Reviews·Kailash Prasad
Sep 5, 2006·Cancer Metastasis Reviews·Frances Balkwill
Sep 12, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danielle L Poulin, James A DeCaprio
Oct 13, 2006·Journal of Leukocyte Biology·Marco E Bianchi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Qianwen HuangJianping Weng
Critical Care : the Official Journal of the Critical Care Forum
Giovanni RivaMario Luppi
© 2021 Meta ULC. All rights reserved